XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Business Combination, Series of Individually Immaterial Business Combinations
2029 Notes:
2025 Notes:
Class A and Class B Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
2029 Notes:
Additional Paid-in Capital
2025 Notes:
Accumulated Other Comprehensive (Loss) Income
(Accumulated Deficit) Retained Earnings
Beginning balance (in shares) at Dec. 31, 2022         319,189,843          
Beginning balance at Dec. 31, 2022 $ 1,410,505       $ 3 $ 1,625,190     $ (12,422) $ (202,266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options (in shares)         6,455,931          
Issuance of common stock upon exercise of stock options 20,924         20,924        
Vesting of restricted and performance stock units (in shares)         4,794,318          
Vesting of restricted and performance stock units 0         0        
Issuance (retirement) of restricted shares of common stock from acquisitions (in shares)         122,224          
Issuance (retirement) of restricted shares of common stock from acquisitions 1,886         1,886        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)         517,430          
Issuance of common stock under the Employee Stock Purchase Plan 37,370         37,370        
Stock-based compensation 495,897         495,897        
Change in accumulated other comprehensive (loss) income 10,204               10,204  
Net (loss) income 48,568                 48,568
Ending balance (in shares) at Dec. 31, 2023         331,079,746          
Ending balance at Dec. 31, 2023 2,025,354       $ 3 2,181,267     (2,218) (153,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options (in shares)         5,123,239          
Issuance of common stock upon exercise of stock options 7,444         7,444        
Vesting of restricted and performance stock units (in shares)         5,329,642          
Issuance (retirement) of restricted shares of common stock from acquisitions (in shares)         136,906          
Issuance (retirement) of restricted shares of common stock from acquisitions 3,705         3,705        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)         449,249          
Issuance of common stock under the Employee Stock Purchase Plan 43,686         43,686        
Stock-based compensation 583,488         583,488        
Equity component of 2029 Convertible Senior Notes, net (83,813)         (83,813)        
Adjustments to additional paid in capital, equity component of convertible debt, settlement of capped calls     $ (100,900) $ 54,136     $ (100,900) $ 54,136    
Change in accumulated other comprehensive (loss) income (2,483)               (2,483)  
Net (loss) income 183,746                 183,746
Ending balance (in shares) at Dec. 31, 2024         342,118,782          
Ending balance at Dec. 31, 2024 $ 2,714,363       $ 3 2,689,013     (4,701) 30,048
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options (in shares) 3,478,500       3,478,500          
Issuance of common stock upon exercise of stock options $ 6,175         6,175        
Vesting of restricted and performance stock units (in shares)         5,595,469          
Issuance (retirement) of restricted shares of common stock from acquisitions (in shares)   770,044                
Issuance (retirement) of restricted shares of common stock from acquisitions 53,038         53,038        
Issuance of common stock under the Employee Stock Purchase Plan (in shares)         569,345          
Issuance of common stock under the Employee Stock Purchase Plan 56,816         56,816        
Stock-based compensation 774,125         774,125        
Settlement of common stock in connection with the 2025 Convertible Senior Notes (in shares)         (6,169)          
Adjustments to additional paid in capital, equity component of convertible debt, settlement of capped calls (157)         (157)        
Change in accumulated other comprehensive (loss) income 20,105               20,105  
Net (loss) income 107,741                 107,741
Ending balance (in shares) at Dec. 31, 2025         352,525,971          
Ending balance at Dec. 31, 2025 $ 3,732,206       $ 3 $ 3,579,010     $ 15,404 $ 137,789